Passage of a new law in Oregon that requires industrial hemp growers to register with the state is seen as a positive move for the industry, advocates of the program are saying.
Articles
Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery
Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
Global Payout, Inc. (GOHE) Subsidiary Ramping-Up Sales and Marketing Efforts for PotSaver Brand
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., is currently in the process of ramping-up its sales and marketing efforts within Los Angeles County for its newly-acquired PotSaver brand.
What Can Canada Learn from the US When it Comes to Cannabis Legalization?
From underage access to taxes and enforcement costs, Canada’s swimming in concerns around the impending legalization of cannabis. Drawing on data from the US’s legal-cannabis states, Leafly addresses each of Canada’s fears by addressing how each has played out south of the border.
The post What Can Canada Learn from the US When it Comes to Cannabis Legalization? appeared first on Leafly.
Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.
Maricann Provides Update on Financing, NanoLeaf Acquisition and Other Matters
Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) announces that insiders of the Company have agreed to purchase $7,000,000 of convertible debenture units (the "Convertible Debenture Units") in its previously announced private placement offering.
Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
Marapharm Ventures Inc. Announces that it has Purchased an Additional 1.5 Million Units of Veritas Pharma Inc.
Marapharm announced today that it has purchased 1,500,000 units of Veritas Pharma Inc. at a purchase price of $0.28 per unit
Copy of Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
Grey Cloak Tech, Inc. (GRCK) Announces Cancellation of Reverse Stock Split
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
SinglePoint, Inc. (SING) CEO Featured in Equities.com Interview
SinglePoint (OTC: SING) was featured in an article published by Equities.com in which the company’s chief executive officer, Greg Lambrecht, was interviewed.
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
Medical Marijuana, Inc. Announces Robert ’Bo’ Brannin as Senior Director of Operations for Subsidiary Kannaway
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that its subsidiary Kannaway® LLC is welcoming Robert "Bo" Brannin as its new Senior Director of Operations.
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.